Literature DB >> 17279724

Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy.

M Regehly1, K Greish, F Rancan, H Maeda, F Böhm, B Röder.   

Abstract

Zn-protoporphyrin (ZnPP) is a promising candidate for cancer therapy. It is known to inhibit heme-oxygenase-1 (HO-1), resulting in suppressed biliverdin/bilirubin production accompanying lowered antioxidative capacity. As a consequence, a significant suppression of tumor growth in vivo was reported. Recent findings also showed that ZnPP efficiently generated reactive singlet oxygen under illumination of visible light. In the present report, we describe the photosensitizing capabilities of water-soluble polymer conjugates of ZnPP as novel compounds for photodynamic therapy against solid tumors. The polymer conjugation made ZnPP water-soluble, thus possible for injection for its aqueous solution. The cellular uptake and photobiological activity of ZnPP derivatives have been tested using a human T-cell leukemia cell line in vitro and demonstrated most potent phototoxic effects of SMA-ZnPP followed by PEG-ZnPP under aerobic conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17279724     DOI: 10.1021/bc060158u

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

1.  A High-Throughput Screening Assay to Identify Kidney Toxic Compounds.

Authors:  Susanne Ramm; Melanie Adler; Vishal S Vaidya
Journal:  Curr Protoc Toxicol       Date:  2016-08-01

2.  Zinc protoporphyrin polymeric nanoparticles: potent heme oxygenase inhibitor for cancer therapy.

Authors:  Hasti Rouhani; Nima Sepehri; Hamed Montazeri; Mohammad Reza Khoshayand; Mohammad Hossein Ghahremani; Seyed Nasser Ostad; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

3.  Synthesis and characterization of mono-, di-, and tri-poly(ethylene glycol) chlorin e6 conjugates for the photokilling of human ovarian cancer cells.

Authors:  Stanley Kimani; Goutam Ghosh; Ashwini Ghogare; Benjamin Rudshteyn; Dorota Bartusik; Tayyaba Hasan; Alexander Greer
Journal:  J Org Chem       Date:  2012-11-14       Impact factor: 4.354

4.  High-yielding syntheses of hydrophilic conjugatable chlorins and bacteriochlorins.

Authors:  Jason R McCarthy; Jayeeta Bhaumik; Nabyl Merbouh; Ralph Weissleder
Journal:  Org Biomol Chem       Date:  2009-07-02       Impact factor: 3.876

5.  A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro.

Authors:  Melanie Adler; Susanne Ramm; Marc Hafner; Jeremy L Muhlich; Esther Maria Gottwald; Elijah Weber; Alenka Jaklic; Amrendra Kumar Ajay; Daniel Svoboda; Scott Auerbach; Edward J Kelly; Jonathan Himmelfarb; Vishal S Vaidya
Journal:  J Am Soc Nephrol       Date:  2015-08-10       Impact factor: 10.121

6.  Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer.

Authors:  Yu Cheng; Anna C Samia; Joseph D Meyers; Irene Panagopoulos; Baowei Fei; Clemens Burda
Journal:  J Am Chem Soc       Date:  2008-07-22       Impact factor: 15.419

7.  Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin.

Authors:  Jun Fang; Long Liao; Hongzhuan Yin; Hideaki Nakamura; Vladimir Subr; Karel Ulbrich; Hiroshi Maeda
Journal:  Future Sci OA       Date:  2015-11-01

8.  Gold nanostructures as a platform for combinational therapy in future cancer therapeutics.

Authors:  Salomeh Jelveh; Devika B Chithrani
Journal:  Cancers (Basel)       Date:  2011-03-04       Impact factor: 6.639

9.  Microgel-encapsulated methylene blue for the treatment of breast cancer cells by photodynamic therapy.

Authors:  Anil Khanal; Minh-Phuong Ngoc Bui; Seong S Seo
Journal:  J Breast Cancer       Date:  2014-03-28       Impact factor: 3.588

10.  Effect of Some Substituents Increasing the Solubility of Zn(II) and Al(III) Phthalocyanines on Their Photophysical Properties.

Authors:  A A Chernonosov; E A Ermilov; B Röder; L I Solovyova; O S Fedorova
Journal:  Bioinorg Chem Appl       Date:  2014-09-11       Impact factor: 7.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.